Steven Cook Sells 1,108 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 1,108 shares of the company’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $25.00, for a total value of $27,700.00. Following the completion of the sale, the chief financial officer owned 187,209 shares in the company, valued at $4,680,225. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Omada Health Stock Performance

Shares of NASDAQ OMDA opened at $22.84 on Wednesday. The stock has a market cap of $1.40 billion, a PE ratio of 456.80 and a beta of 1.85. The business has a fifty day moving average of $22.50 and a two-hundred day moving average of $17.38. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.10. The company had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. Analysts predict that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Evercore reaffirmed an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Morgan Stanley reiterated an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a research note on Monday, June 22nd. Weiss Ratings upgraded Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday, August 11th. Canaccord Genuity Group raised their price target on Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a report on Tuesday, July 21st. Finally, The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Eleven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $26.50.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Quarry LP acquired a new stake in shares of Omada Health in the 4th quarter valued at $29,000. Raymond James Financial Inc. acquired a new position in shares of Omada Health during the second quarter valued at $32,000. Versant Capital Management Inc boosted its holdings in Omada Health by 319.3% in the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after acquiring an additional 2,283 shares during the last quarter. Strs Ohio increased its position in Omada Health by 151.0% in the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after purchasing an additional 2,567 shares during the period. Finally, New York State Common Retirement Fund acquired a new stake in Omada Health in the fourth quarter worth about $73,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.